Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-12 4:57 pm Sale | 2023-12-31 | 13G | Evolus, Inc. EOLS | FIRST MANHATTAN CO. LLC. | 490,000 0.860% | -3,840,738 (-88.69%) | Filing History |
| 2024-01-29 5:25 pm Purchase | 2023-12-31 | 13G | Evolus, Inc. EOLS | BlackRock Inc. BLK | 3,339,377 5.800% | 1,686,774 (+102.07%) | Filing History |
| 2023-11-27 4:16 pm Purchase | 2023-11-15 | 13G | Evolus, Inc. EOLS | Perceptive Advisors LLC | 3,086,604 5.400% | 3,086,604 (New Position) | Filing History |
| 2023-10-18 4:17 pm Sale | 2023-10-16 | 13G | Evolus, Inc. EOLS | Medytox Inc. | 3,381,326 5.900% | -3,915,217 (-53.66%) | Filing History |
| 2023-10-04 5:08 pm Sale | 2023-10-04 | 13G | Evolus, Inc. EOLS | Deerfield Mgmt, L.P. | 1,784 0.000% | -3,317,216 (-99.95%) | Filing History |
| 2023-08-14 4:05 pm Sale | 2023-02-17 | 13D | Evolus, Inc. EOLS | Alphaeon 1 LLC | 0 0.000% | -6,064,871 (Position Closed) | Filing History |
| 2023-06-16 4:54 pm Purchase | 2023-06-19 | 13G | Evolus, Inc. EOLS | Stonepine Capital Management, LLC | 4,187,447 7.400% | 4,187,447 (New Position) | Filing History |
| 2023-05-09 4:23 pm Sale | 2023-05-08 | 13G | Evolus, Inc. EOLS | Millennium Management LLC | 2,599,711 4.600% | -728,886 (-21.90%) | Filing History |
| 2023-02-21 4:00 pm Purchase | 2023-02-10 | 13G | Evolus, Inc. EOLS | TANG CAPITAL PARTNERS LP | 3,038,732 5.400% | 3,038,732 (New Position) | Filing History |
| 2023-02-15 4:00 pm Purchase | 2023-02-06 | 13G | Evolus, Inc. EOLS | Millennium Management LLC | 3,328,597 5.900% | 3,328,597 (New Position) | Filing History |
| 2023-02-14 2:32 pm Purchase | 2022-12-31 | 13G | Evolus, Inc. EOLS | FIRST MANHATTAN CO. LLC. | 4,330,738 7.700% | 995,822 (+29.86%) | Filing History |
| 2023-02-10 09:32 am Purchase | 2022-12-31 | 13G | Evolus, Inc. EOLS | Deerfield Mgmt, L.P. | 3,319,000 5.900% | 288,701 (+9.53%) | Filing History |
| 2023-02-06 4:12 pm Sale | 2022-12-31 | 13G | Evolus, Inc. EOLS | Medytox Inc. | 7,296,543 12.970% | -167,109 (-2.24%) | Filing History |
| 2022-06-06 4:53 pm Purchase | 2022-05-25 | 13G | Evolus, Inc. EOLS | Deerfield Mgmt, L.P. | 3,030,299 5.410% | 3,030,299 (New Position) | Filing History |
| 2022-02-14 6:16 pm Purchase | 2021-12-31 | 13G | Evolus, Inc. EOLS | FIRST MANHATTAN CO. LLC. | 3,334,916 6.000% | 3,334,916 (New Position) | Filing History |
| 2022-02-08 9:55 pm Purchase | 2021-12-31 | 13G | Evolus, Inc. EOLS | Medytox Inc. | 7,463,652 13.430% | 701,000 (+10.37%) | Filing History |
| 2021-09-27 4:22 pm Unchanged | 2021-09-02 | 13D | Evolus, Inc. EOLS | Alphaeon 1 LLC | 6,064,871 11.100% | 0 (Unchanged) | Filing History |
| 2021-09-17 7:50 pm Sale | 2021-09-02 | 13D | Evolus, Inc. EOLS | Alphaeon 1 LLC | 6,064,871 11.100% | -2,597,475 (-29.99%) | Filing History |
| 2021-04-01 1:24 pm Purchase | 2021-03-25 | 13G | Evolus, Inc. EOLS | Daewoong Pharmaceutical Co. Ltd. | 3,136,869 7.200% | 3,136,869 (New Position) | Filing History |
| 2021-03-01 5:22 pm Purchase | 2021-02-18 | 13G | Evolus, Inc. EOLS | Medytox Inc. | 6,762,652 16.700% | 6,762,652 (New Position) | Filing History |